Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 12112-12122

  Ai, Youwei ^a,b   Zhu, Dantong ^a,b   Wang, Cuihui ^a   Su, Chao ^a   Ma, Jian ^a   Ma, Jianzhang ^b   Wang, Xiaojun ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; CORE BINDING FACTOR BETA; HYDROLASE; UNCLASSIFIED DRUG; VIF PROTEIN; APOBEC3 PROTEIN, HUMAN; CBFB PROTEIN, HUMAN; CYTOSINE DEAMINASE; PRIMER DNA;

ARTICLE; BOVINE IMMUNODEFICIENCY LIKE VIRUS; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; FELINE IMMUNODEFICIENCY VIRUS; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; VISNA VIRUS; CLASSIFICATION; HEK293 CELL LINE; LENTIVIRINAE; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CORE BINDING FACTOR BETA SUBUNIT; CYTOSINE DEAMINASE; DNA PRIMERS; GENE PRODUCTS, VIF; HEK293 CELLS; HUMANS; LENTIVIRUS; PROTEOLYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84907917263     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01924-14     Document Type: Article

References (62)

1. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650. http://dx.doi.org/10.1038 /nature00939.
2. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31. http: //dx.doi.org/10.1016/S0092-8674(03)00515-4.
3. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809. http://dx.doi.org/10.1016/S0092-8674(03)00423-9.
4. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112. http://dx.doi.org/10.1126/science.1083338.
5. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103. http://dx.doi.org/10.1038/nature01709.
6. Marin M, Rose KM, Kozak SL, Kabat D. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-1403. http://dx.doi.org/10.1038/nm946.
7. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98. http://dx.doi.org/10.1038 /nature01707.
8. Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, Sheehy AM. 2005. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15:166-170. http://dx.doi.org/10.1016/j.cub.2004.12.068.
9. Turelli P, Trono D. 2005. Editing at the crossroad of innate and adaptive immunity. Science 307:1061-1065. http://dx.doi.org/10.1126/science.1105964.
10. Rose KM, Marin M, Kozak SL, Kabat D. 2004. The viral infectivity factor (Vif) of HIV-1 unveiled. Trends Mol. Med. 10:291-297. http://dx.doi.org /10.1016/j.molmed.2004.04.008.
11. Bieniasz PD. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109-1115. http://dx.doi.org/10.1038/ni1125.
12. Conticello SG, Harris RS, Neuberger MS. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13:2009-2013. http://dx.doi.org/10.1016/j.cub.2003.10.034.
13. Liu B, Yu X, Luo K, Yu Y, Yu XF. 2004. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J. Virol. 78:2072-2081. http://dx.doi.org /10.1128/JVI.78.4.2072-2081.2004.
14. Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. 2004. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279: 7792-7798. http://dx.doi.org/10.1074/jbc.M313093200.
15. Sheehy AM, Gaddis NC, Malim MH. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:1404-1407. http://dx.doi.org/10.1038/nm945.
16. Stopak K, de Noronha C, Yonemoto W, Greene WC. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12:591-601. http://dx.doi.org/10.1016/S1097-2765(03)00353-8.
17. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060. http://dx.doi.org/10.1126/science.1089591.
18. Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D. 2004. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18:2861-2866. http://dx.doi.org/10.1101/gad.1249904.
19. Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF. 2004. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18:2867-2872. http://dx.doi.org/10.1101/gad.1250204.
20. Stanley BJ, Ehrlich ES, Short L, Yu Y, Xiao Z, Yu XF, Xiong Y. 2008. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J. Virol. 82:8656-8663. http://dx.doi.org/10.1128/JVI.00767-08.
21. Luo K, Xiao Z, Ehrlich E, Yu Y, Liu B, Zheng S, Yu XF. 2005. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc. Natl. Acad. Sci. U. S. A. 102:11444-11449. http://dx.doi.org/10.1073 /pnas.0502440102.
22. Mehle A, Thomas ER, Rajendran KS, Gabuzda D. 2006. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J. Biol. Chem. 281:17259-17265. http://dx.doi.org/10.1074/jbc.M602413200.
23. Paul I, Cui J, Maynard EL. 2006. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 103: 18475-18480. http://dx.doi.org/10.1073/pnas.0604150103.
24. Xiao Z, Ehrlich E, Yu Y, Luo K, Wang T, Tian C, Yu XF. 2006. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349:290-299. http: //dx.doi.org/10.1016/j.virol.2006.02.002.
25. Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF. 2007. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J. 21:217-222.
26. Dang Y, Wang X, Zhou T, York IA, Zheng YH. 2009. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization. J. Virol. 83:8544-8552. http: //dx.doi.org/10.1128/JVI.00651-09.
27. Dang Y, Wang X, York IA, Zheng YH. 2010. Identification of a critical T(Q./D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J. Virol. 84: 8561-8570. http://dx.doi.org/10.1128/JVI.00960-10.
28. Lu Z, Bergeron JR, Atkinson RA, Schaller T, Veselkov DA, Oregioni A, Yang Y, Matthews SJ, Malim MH, andSanderson MR. 2013. Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction. Open Biol. 3:130100. http://dx.doi.org/10.1098/rsob.130100.
29. Jäger S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, Mahon C, Kane J, Franks-Skiba K, Cimermancic P, Burlingame A, Sali A, Craik CS, Harris RS, Gross JD, Krogan NJ. 2012. Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 481:371-375. http://dx.doi.org/10.1038 /nature10693.
30. Zhang W, Du J, Evans SL, Yu Y, Yu XF. 2012. T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481:376-379. http://dx.doi.org/10.1038/nature10718.
31. Hultquist JF, McDougle RM, Anderson BD, Harris RS. 2012. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor beta on genetically distinct surfaces. AIDS Res. Hum. Retroviruses 28:1543-1551. http://dx.doi.org/10.1089/aid.2012.0142.
32. Salter JD, Lippa GM, Belashov IA, Wedekind JE. 2012. Core-binding factor beta increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex. Biochemistry 51:8702-8704. http://dx.doi.org/10.1021/bi301244z.
33. Hultquist JF, Binka M, LaRue RS, Simon V, Harris RS. 2012. Vif proteins of human and simian immunodeficiency viruses require cellular CBFbeta to degrade APOBEC3 restriction factors. J. Virol. 86:2874-2877. http://dx.doi.org/10.1128/JVI.06950-11.
34. Zhou X, Evans SL, Han X, Liu Y, Yu XF. 2012. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFbeta and CRL5 E3 ubiquitin ligase components. PLoS One 7:e33495. http://dx.doi.org/10.1371/journal.pone.0033495.
35. Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ, Gross JD. 2013. CBFbeta stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol. Cell 49:632-644. http://dx.doi.org/10.1016/j.molcel.2012.12.012.
36. Zhou X, Han X, Zhao K, Du J, Evans SL, Wang H, Li P, Zheng W, Rui Y, Kang J, Yu XF. 2014. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFbeta recruitment and A3G suppression. J. Virol. 88:2555-2563. http://dx.doi.org/10.1128/JVI.03604-13.
37. Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y. 2014. Core binding factor beta plays a critical role by facilitating the assembly of the vif-cullin 5 e3 ubiquitin ligase. J. Virol. 88:3309-3319. http://dx.doi.org/10.1128/JVI.03824-13.
38. Miyagi E, Kao S, Yedavalli V, Strebel K. 2014. CBFbeta enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G. J. Virol. 88: 4839-4852. http://dx.doi.org/10.1128/JVI.03359-13.
39. Ito Y. 2008. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 99:33-76. http://dx.doi.org/10.1016/S0065-230X(07)99002-8.
40. de Bruijn MF, Speck NA. 2004. Core-binding factors in hematopoiesis and immune function. Oncogene 23:4238-4248. http://dx.doi.org/10.1038/sj.onc.1207763.
41. Klunker S, Chong MM, Mantel PY, Palomares O, Bassin C, Ziegler M, Ruckert B, Meiler F, Akdis M, Littman DR, Akdis CA. 2009. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med. 206:2701-2715. http://dx.doi.org/10.1084/jem.20090596.
42. Kitoh A, Ono M, Naoe Y, Ohkura N, Yamaguchi T, Yaguchi H, Kitabayashi I, Tsukada T, Nomura T, Miyachi Y, Taniuchi I, Sakaguchi S. 2009. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 31:609-620. http://dx.doi.org/10.1016/j.immuni.2009.09.003.
43. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13: 3324-3339.
44. Pepling ME, Gergen JP. 1995. Conservation and function of the transcriptional regulatory protein Runt. Proc. Natl. Acad. Sci. U. S. A. 92: 9087-9091. http://dx.doi.org/10.1073/pnas.92.20.9087.
45. Kim WY, Sieweke M, Ogawa E, Wee HJ, Englmeier U, Graf T, Ito Y. 1999. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18:1609-1620. http://dx.doi.org/10.1093/emboj/18.6.1609.
46. Tang YY, Crute BE, Kelley JJ, Huang X, Yan J, Shi J, Hartman KL, Laue TM, Speck NA, Bushweller JH. 2000. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA. FEBS Lett. 470:167-172. http://dx.doi.org/10.1016 /S0014-5793(00)01312-0.
47. LaRue RS, Jonsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, Hotzel I, Andresdottir V, Smith TP, Harris RS. 2008. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 9:104. http://dx.doi.org/10.1186/1471-2199-9-104.
48. Larue RS, Lengyel J, Jonsson SR, Andresdottir V, Harris RS. 2010. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J. Virol. 84:8193-8201. http://dx.doi.org/10.1128/JVI.00685-10.
49. Wang J, Zhang W, Lv M, Zuo T, Kong W, Yu X. 2011. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins. J. Virol. 85: 12482-12491. http://dx.doi.org/10.1128/JVI.05218-11.
50. Wang X, Abudu A, Son S, Dang Y, Venta PJ, Zheng YH. 2011. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J. Virol. 85:3142-3152. http://dx.doi.org/10.1128/JVI.02049-10.
51. Yin X, Hu Z, Gu Q, Wu X, Zheng YH, Wei P, Wang X. 2014. Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein. J. Virol. 88:1259-1270. http: //dx.doi.org/10.1128/JVI.03148-13.
52. Zielonka J, Marino D, Hofmann H, Yuhki N, Lochelt M, Munk C. 2010. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 84:7312-7324. http://dx.doi.org/10.1128/JVI.00209-10.
53. Yang S, Sun Y, Zhang H. 2001. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J. Biol. Chem. 276:4889-4893. http://dx.doi.org/10.1074 /jbc.M004895200.
54. Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H. 2003. Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins. J. Biol. Chem. 278:6596-6602. http://dx.doi.org/10.1074/jbc.M210164200.
55. Batisse J, Guerrero SX, Bernacchi S, Richert L, Godet J, Goldschmidt V, Mely Y, Marquet R, de Rocquigny H, Paillart JC. 2013. APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells. J. Virol. 87:6492-6506. http://dx.doi.org/10.1128/JVI.03494-12.
56. Guo Y, Dong L, Qiu X, Wang Y, Zhang B, Liu H, Yu Y, Zang Y, Yang M, Huang Z. 2014. Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif. Nature 505:229-233. http://dx.doi.org/10.1038/nature12884.
57. Wang X, Dolan PT, Dang Y, Zheng YH. 2007. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle. J. Biol. Chem. 282:1585-1594. http://dx.doi.org/10.1074/jbc.M610150200.
58. Du J, Zhao K, Rui Y, Li P, Zhou X, Zhang W, Yu XF. 2013. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta. J. Virol. 87: 1906-1911. http://dx.doi.org/10.1128/JVI.02199-12.
59. Han X, Liang W, Hua D, Zhou X, Du J, Evans SL, Gao Q, Wang H, Viqueira R, Wei W, Zhang W, Yu XF. 2014. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-Cullin 5-RING E3 ubiquitin ligase. J. Virol. 88:3320-3328. http://dx.doi.org/10.1128/JVI.03833-13.
60. Matsui Y, Shindo K, Nagata K, Io K, Tada K, Iwai F, Kobayashi M, Kadowaki N, Harris RS, Takaori-Kondo A. 2014. Defining HIV-1 Vif residues that interact with CBFbeta by site-directed mutagenesis. Virology 449:82-87. http://dx.doi.org/10.1016/j.virol.2013.11.004.
61. Wang H, Liu B, Liu X, Li Z, Yu XF, Zhang W. 2014. Identification of HIV-1 Vif regions required for CBF-beta interaction and APOBEC3 suppression. PLoS One 9:e95738. http://dx.doi.org/10.1371/journal.pone.0095738.
62. Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK. 2014. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J. Mol. Biol. 426:1220-1245. http://dx.doi.org/10.1016/j.jmb.2013.10.033.